MCID: TST014
MIFTS: 46

Testicular Cancer

Categories: Cancer diseases, Reproductive diseases

Aliases & Classifications for Testicular Cancer

MalaCards integrated aliases for Testicular Cancer:

Name: Testicular Cancer 12 36 54 42 15
Malignant Neoplasm of Testis 71 32
Testicular Carcinoma 54 17
Testicular Neoplasms 43 71
Testicular Malignant Germ Cell Tumor 71
Childhood Neoplasm of the Testis 12
Pediatric Testicular Neoplasm 12
Childhood Testicular Neoplasm 71
Carcinoma of the Testis 71
Testicular Neoplasm 17
Neoplasm of Testis 12
Testicular Tumors 15
Testicular Tumor 12
Testis Neoplasm 12
Testis Cancer 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2998
KEGG 36 H00023
ICD9CM 34 186
MeSH 43 D013736
SNOMED-CT 67 126900000 363449006
ICD10 32 C62 C62.9
UMLS 71 C0039590 C0153594 C0677483 more

Summaries for Testicular Cancer

MedlinePlus : 42 Testicles, or testes, make male hormones and sperm. They are two egg-shaped organs inside the scrotum, the loose sac of skin behind the penis. You can get cancer in one or both testicles. Testicular cancer mainly affects young men between the ages of 20 and 39. It is also more common in men who Have had abnormal testicle development Have had an undescended testicle Have a family history of the cancer Symptoms include pain, swelling, or lumps in your testicles or groin area. Doctors use a physical exam, lab tests, imaging tests, and a biopsy to diagnose testicular cancer. Most cases can be treated, especially if found early. Treatment options include surgery, radiation, and/or chemotherapy. Regular exams after treatment are important. Treatments may also cause infertility. If you may want children later on, you should consider sperm banking before treatment. NIH: National Cancer Institute

MalaCards based summary : Testicular Cancer, also known as malignant neoplasm of testis, is related to testicular seminoma and cryptorchidism, unilateral or bilateral. An important gene associated with Testicular Cancer is TDRG1 (Testis Development Related 1). The drugs Testosterone and Methyltestosterone have been mentioned in the context of this disorder. Affiliated tissues include testicles, testis and lymph node.

Disease Ontology : 12 A male reproductive system cancer that is located in the testicles.

KEGG : 36 Testicular germ cell tumor (TGCT) comprises about 98% of all testicular neoplasms and is thereby the most common malignancy among young males. Overall, three different entities of TGCT can be distinguished: teratomas and yolk sac tumors of newborns and infants, seminomatous and nonseminomatous germ cell tumors of adolescents and young adults, and spermatocytic seminoma of elderly men. Recent studies of TGCTs have suggested that overexpression of cyclin D2 is a very early, possibly the oncogenic, event in GC tumorigenesis.

Wikipedia : 74 Testicular cancer is cancer that develops in the testicles, a part of the male reproductive system.... more...

Related Diseases for Testicular Cancer

Diseases related to Testicular Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 538, show less)
# Related Disease Score Top Affiliating Genes
1 testicular seminoma 33.2 CGB3 AFP
2 cryptorchidism, unilateral or bilateral 33.1 SHBG RXFP2 INSL3 CGB5 AFP
3 testicular disease 33.0 RXFP2 MIR199A1 INSL3 AFP
4 testicular leydig cell tumor 32.8 INSL3 CGB3
5 nonseminomatous germ cell tumor 32.0 CGB5 AFP
6 teratoma 31.9 CGB5 CGB3 AFP
7 germ cell cancer 31.5 MIR199A1 ALPP AFP
8 testicular germ cell tumor 31.3 STK11 CGB3 ALPP AFP
9 endodermal sinus tumor 31.3 MIR199A1 CGB3 AFP
10 seminoma 31.2 SSX2 MAGEA4 CGB5 CGB3 ALPP AFP
11 mixed germ cell tumor 31.0 CGB3 AFP
12 extragonadal germ cell cancer 31.0 CGB5 AFP
13 choriocarcinoma 30.9 CGB5 CGB3 ALPP
14 malignant teratoma 30.9 CGB5 AFP
15 chromosomal triplication 30.8 CGB3 AFP
16 testicular torsion 30.8 RXFP2 INSL3 CGB5
17 embryonal testis carcinoma 30.5 MIR199A1 AFP
18 gonadal germ cell tumor 30.5 CGB5 AFP
19 gonadoblastoma 30.3 CGB5 CGB3 ALPP
20 tuberculous epididymitis 30.3 CGB3 AFP
21 disorders of sexual development 30.3 SHBG RXFP2 INSL3 AFP
22 gonadal dysgenesis 30.2 SHBG CGB5 CGB3
23 spermatocytoma 30.2 SSX2 MAGEA4 AFP
24 germinoma 30.2 CGB5 CGB3 ALPP AFP
25 squamous cell carcinoma 29.5 STK11 MAGEA4 MAGEA1 CTAG1B BOK-AS1
26 esophageal cancer 29.2 XIST STK11 MIR199A1 MAGEA4 MAGEA1 ERCC1
27 rete testis neoplasm 12.4
28 embryonal carcinoma 11.7
29 testicular germ cell cancer 11.6
30 testis sarcoma 11.2
31 testis refractory cancer 11.2
32 spermatocele 11.2
33 sex cord-gonadal stromal tumor 11.2
34 testicular brenner tumor 11.2
35 gynandroblastoma 11.2
36 germ cells tumors 10.8
37 anorchia 10.6 RXFP2 INSL3 CGB5
38 mature teratoma 10.6
39 corpus luteum cyst 10.6 CGB5 AFP
40 infertility 10.5
41 in situ carcinoma 10.5
42 ectopic pregnancy 10.5 CGB5 CGB3 AFP
43 hypogonadism 10.5
44 brain germinoma 10.5 MAGEA4 AFP
45 microinvasive gastric cancer 10.5 XIST TDRG1 AFP
46 azoospermia 10.5
47 placenta disease 10.4 MIR199A1 CGB5 CGB3 AFP
48 sexual disorder 10.4
49 impotence 10.4
50 epidermoid cysts 10.4
51 testicular microlithiasis 10.4
52 mediastinum seminoma 10.4 ALPP AFP
53 teratocarcinoma 10.4
54 lipoid congenital adrenal hyperplasia 10.4
55 testicular yolk sac tumor 10.3
56 raynaud phenomenon 10.3
57 aromatase excess syndrome 10.3 SHBG CGB5
58 hepatic tuberculosis 10.3 ALPP AFP
59 malignant tumor of undescended testis 10.3
60 testicular sex cord-stromal neoplasm 10.3
61 inguinal hernia 10.3
62 neuropathy 10.3
63 sarcoidosis 1 10.3
64 peripheral nervous system disease 10.3
65 placental site trophoblastic tumor 10.3 CGB5 CGB3
66 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 10.3
67 neutropenia 10.3
68 male infertility 10.3
69 adrenogenital syndrome 10.2
70 mucositis 10.2
71 infant gynecomastia 10.2
72 gynecomastia 10.2
73 pulmonary embolism 10.2
74 thrombocytopenia 10.2
75 granulocytopenia 10.2
76 hypospadias 10.1
77 ileus 10.1
78 encephalitis 10.1
79 precocious puberty 10.1
80 cellular myxoid liposarcoma 10.1 SSX2 CTAG1B
81 bladder cancer 10.1
82 hypercholesterolemia, familial, 1 10.1
83 ascites, chylous 10.1
84 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.1
85 leukemia, acute myeloid 10.1
86 orchitis 10.1
87 rhabdomyosarcoma 10.1
88 hydatidiform mole, recurrent, 1 10.1 CGB5 CGB3
89 wilms tumor 5 10.1
90 body mass index quantitative trait locus 1 10.1
91 gastric cancer 10.1
92 thrombosis 10.1
93 mumps 10.1
94 sensory peripheral neuropathy 10.1
95 alopecia 10.1
96 polyarteritis nodosa 10.1
97 sarcomatoid renal cell carcinoma 10.1 SSX2 CGB3
98 thrombophilia due to thrombin defect 10.0
99 down syndrome 10.0
100 lymphoma, hodgkin, classic 10.0
101 pancreatic cancer 10.0
102 myocardial infarction 10.0
103 leukemia 10.0
104 polyneuropathy 10.0
105 oligospermia 10.0
106 pneumothorax 10.0
107 kidney cancer 10.0
108 skin carcinoma 10.0
109 hydrocele 10.0
110 limbic encephalitis 10.0
111 rare tumor 10.0
112 benign teratoma 10.0
113 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
114 angina pectoris 10.0
115 lymphoma 10.0
116 dermatomyositis 10.0
117 sarcoma 10.0
118 respiratory failure 10.0
119 penile cancer 10.0
120 diarrhea 10.0
121 pulmonary fibrosis 10.0
122 spindle cell sarcoma 10.0
123 kidney disease 10.0
124 paralytic ileus 10.0
125 47,xyy 10.0
126 malignant tumor of penis 10.0
127 thyroid carcinoma 10.0
128 leiomyoma 10.0
129 48,xyyy 10.0
130 renal cell carcinoma, nonpapillary 9.9
131 ovarian cancer 9.9
132 pneumothorax, primary spontaneous 9.9
133 androgen insensitivity syndrome 9.9
134 anxiety 9.9
135 ectodermal dysplasia-syndactyly syndrome 2 9.9
136 colitis 9.9
137 desmoid tumor 9.9
138 pre-eclampsia 9.9
139 hydronephrosis 9.9
140 vascular disease 9.9
141 benign mesothelioma 9.9
142 adenocarcinoma 9.9
143 chronic kidney disease 9.9
144 testicular spermatocytic seminoma 9.9
145 learning disability 9.9
146 acute myocardial infarction 9.9
147 paraneoplastic limbic encephalitis 9.9
148 avascular necrosis 9.9
149 burkitt lymphoma 9.9
150 reticulum cell sarcoma 9.9
151 hematocele of tunica vaginalis testis 9.9
152 adrenal rest tumor 9.9
153 hemangioma 9.9
154 ichthyosis, x-linked 9.9
155 ichthyosis 9.9
156 encephalopathy 9.9
157 neurofibromatosis, type ii 9.8
158 breast cancer 9.8
159 colorectal cancer 9.8
160 fibrosis of extraocular muscles, congenital, 1 9.8
161 osteoporosis 9.8
162 peutz-jeghers syndrome 9.8
163 prostate cancer 9.8
164 hemochromatosis, type 1 9.8
165 myeloma, multiple 9.8
166 osteogenic sarcoma 9.8
167 spermatogenic failure, x-linked, 1 9.8
168 lymphoma, non-hodgkin, familial 9.8
169 coronary heart disease 1 9.8
170 bone mineral density quantitative trait locus 8 9.8
171 leukemia, acute lymphoblastic 9.8
172 bone mineral density quantitative trait locus 15 9.8
173 peripheral vascular disease 9.8
174 exanthem 9.8
175 cardiac arrest 9.8
176 renal hypoplasia 9.8
177 osteonecrosis 9.8
178 testicular lymphoma 9.8
179 varicocele 9.8
180 acute leukemia 9.8
181 urticaria 9.8
182 rectum cancer 9.8
183 neonatal jaundice 9.8
184 acute kidney failure 9.8
185 lipid metabolism disorder 9.8
186 liposarcoma 9.8
187 syphilis 9.8
188 lymphocele 9.8
189 dysgerminoma 9.8
190 retroperitoneal germ cell neoplasm 9.8
191 compartment syndrome 9.8
192 peptic ulcer disease 9.8
193 lung disease 9.8
194 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.8
195 measles 9.8
196 radiation induced cancer 9.8
197 back pain 9.8
198 paraneoplastic syndromes 9.8
199 lipomatosis, multiple 9.8
200 scott syndrome 9.8
201 pleomorphic lipoma 9.8
202 granulomatous orchitis 9.8
203 neurilemmoma 9.8
204 plasmacytoma 9.8
205 adenoma 9.8
206 acth-secreting pituitary adenoma 9.8
207 reticulosarcoma 9.8
208 epididymo-orchitis 9.8
209 polyembryoma 9.8
210 argyria 9.8
211 sarcoma, synovial 9.8 SSX2 MAGEA1 CTAG1B
212 dowling-degos disease 1 9.8
213 aortic dissection 9.8
214 filariasis 9.8
215 pulmonary sarcoidosis 9.8
216 epilepsy 9.8
217 larynx cancer 9.8
218 capillary hemangioma 9.8
219 mixed germ cell-sex cord neoplasm 9.8
220 papillary carcinoma 9.8
221 temporal lobe epilepsy 9.8
222 neurotic disorder 9.8
223 testicular infarct 9.8
224 monocytic leukemia 9.8
225 herpes zoster 9.8
226 cerebellar degeneration 9.8
227 diffuse large b-cell lymphoma 9.7
228 cardiac tamponade 9.7
229 acute kidney tubular necrosis 9.7
230 premature ejaculation 9.7
231 urethral stricture 9.7
232 acute pancreatitis 9.7
233 skin disease 9.7
234 chronic pain 9.7
235 acanthosis nigricans 9.7
236 retinal detachment 9.7
237 yemenite deaf-blind hypopigmentation syndrome 9.7
238 atrial fibrillation 9.7
239 ptosis 9.7
240 cortical blindness 9.7
241 coronary thrombosis 9.7
242 hairy cell leukemia 9.7
243 cryoglobulinemia 9.7
244 pleural empyema 9.7
245 exophthalmos 9.7
246 pathologic nystagmus 9.7
247 46, xy disorders of sexual development 9.7
248 overgrowth syndrome 9.7
249 achondroplasia 9.7
250 alcohol dependence 9.7
251 antipyrine metabolism 9.7
252 atherosclerosis susceptibility 9.7
253 machado-joseph disease 9.7
254 cardiac arrhythmia 9.7
255 hypercalcemia, infantile, 1 9.7
256 hypertriglyceridemia, familial 9.7
257 ige responsiveness, atopic 9.7
258 kaposi sarcoma 9.7
259 mastocytosis, cutaneous 9.7
260 mesothelioma, malignant 9.7
261 migraine with or without aura 1 9.7
262 polycystic liver disease 1 with or without kidney cysts 9.7
263 mccune-albright syndrome 9.7
264 retinoblastoma 9.7
265 silver-russell syndrome 1 9.7
266 neural tube defects 9.7
267 tobacco addiction 9.7
268 trichorhinophalangeal syndrome, type iii 9.7
269 tuberous sclerosis 1 9.7
270 wilms tumor 1 9.7
271 autism 9.7
272 buerger disease 9.7
273 lung cancer 9.7
274 cystic fibrosis 9.7
275 wolfram syndrome 1 9.7
276 enterocolitis 9.7
277 immune deficiency disease 9.7
278 primrose syndrome 9.7
279 xeroderma pigmentosum, complementation group c 9.7
280 xeroderma pigmentosum, variant type 9.7
281 agammaglobulinemia, x-linked 9.7
282 androgen insensitivity, partial 9.7
283 ataxia and polyneuropathy, adult-onset 9.7
284 aging 9.7
285 stroke, ischemic 9.7
286 cervical cancer 9.7
287 gastrointestinal stromal tumor 9.7
288 creatinine clearance quantitative trait locus 9.7
289 neutrophilic dermatosis, acute febrile 9.7
290 endometrial cancer 9.7
291 leukemia, chronic myeloid 9.7
292 aplastic anemia 9.7
293 histiocytoma, angiomatoid fibrous 9.7
294 aspergillosis 9.7
295 myelodysplastic syndrome 9.7
296 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.7
297 alacrima, achalasia, and mental retardation syndrome 9.7
298 leukemia, acute lymphoblastic 3 9.7
299 pachyonychia congenita 3 9.7
300 alpha-fetoprotein, hereditary persistence of 9.7
301 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.7
302 aspiration pneumonia 9.7
303 inflammatory bowel disease 9.7
304 extrapulmonary tuberculosis 9.7
305 mantle cell lymphoma 9.7
306 hemorrhagic cystitis 9.7
307 oral squamous cell carcinoma 9.7
308 inflammatory myofibroblastic tumor 9.7
309 aphasia 9.7
310 hepatoid adenocarcinoma 9.7
311 bone resorption disease 9.7
312 spina bifida occulta 9.7
313 myoglobinuria 9.7
314 covid-19 9.7
315 hypogonadotropic hypogonadism 9.7
316 castleman disease 9.7
317 osteomyelitis 9.7
318 rickets 9.7
319 portal hypertension 9.7
320 hydrocephalus 9.7
321 amnestic disorder 9.7
322 hemiplegia 9.7
323 disseminated intravascular coagulation 9.7
324 chlamydia 9.7
325 heart disease 9.7
326 horner's syndrome 9.7
327 visual epilepsy 9.7
328 coronary artery vasospasm 9.7
329 allergic hypersensitivity disease 9.7
330 spinal muscular atrophy 9.7
331 pancytopenia 9.7
332 neurosarcoidosis 9.7
333 tuberous sclerosis 9.7
334 eclampsia 9.7
335 toxic shock syndrome 9.7
336 obstructive hydrocephalus 9.7
337 autosomal dominant cerebellar ataxia 9.7
338 renovascular hypertension 9.7
339 cystitis 9.7
340 heart septal defect 9.7
341 atrial heart septal defect 9.7
342 hyperuricemia 9.7
343 gestational choriocarcinoma 9.7
344 hepatitis b 9.7
345 constipation 9.7
346 carbuncle 9.7
347 thrombocytosis 9.7
348 colon adenocarcinoma 9.7
349 arteriosclerosis 9.7
350 basal cell carcinoma 9.7
351 agammaglobulinemia 9.7
352 cystic teratoma 9.7
353 transitional cell carcinoma 9.7
354 leydig cell tumor 9.7
355 bilirubin metabolic disorder 9.7
356 glucosephosphate dehydrogenase deficiency 9.7
357 pulmonary tuberculosis 9.7
358 glioblastoma multiforme 9.7
359 astrocytoma 9.7
360 embryonal rhabdomyosarcoma 9.7
361 ischemia 9.7
362 purpura 9.7
363 plague 9.7
364 sertoli cell tumor 9.7
365 plexopathy 9.7
366 pseudohermaphroditism 9.7
367 pancreatic adenocarcinoma 9.7
368 secondary syphilis 9.7
369 hypertrichosis 9.7
370 myopathy 9.7
371 neuromuscular disease 9.7
372 fibrous histiocytoma 9.7
373 clear cell renal cell carcinoma 9.7
374 familial retinoblastoma 9.7
375 ureteral obstruction 9.7
376 human immunodeficiency virus infectious disease 9.7
377 dysgerminoma of ovary 9.7
378 choriocarcinoma of the testis 9.7
379 extragonadal seminoma 9.7
380 testis seminoma 9.7
381 nephrolithiasis 9.7
382 congestive heart failure 9.7
383 paraplegia 9.7
384 lymphopenia 9.7
385 severe combined immunodeficiency 9.7
386 acquired immunodeficiency syndrome 9.7
387 b-cell lymphoma 9.7
388 intermediate malignant teratoma 9.7
389 pineal region germinoma 9.7
390 adenomatoid tumor 9.7
391 muscular atrophy 9.7
392 neuroblastoma 9.7
393 polycythemia 9.7
394 collagen disease 9.7
395 vasculitis 9.7
396 chickenpox 9.7
397 myeloid sarcoma 9.7
398 myeloid leukemia 9.7
399 rubella 9.7
400 narcolepsy 9.7
401 priapism 9.7
402 fasciitis 9.7
403 necrotizing fasciitis 9.7
404 stomatitis 9.7
405 lymph node disease 9.7
406 toxoplasmosis 9.7
407 hypereosinophilic syndrome 9.7
408 acute myeloblastic leukemia with maturation 9.7
409 dwarfism 9.7
410 glioma 9.7
411 horseshoe kidney 9.7
412 leukoplakia 9.7
413 nephrogenic systemic fibrosis 9.7
414 nodular regenerative hyperplasia 9.7
415 oral leukoplakia 9.7
416 partial deletion of y 9.7
417 polymyositis 9.7
418 pure autonomic failure 9.7
419 reversible cerebral vasoconstriction syndrome 9.7
420 soft tissue sarcoma 9.7
421 teratoma with malignant transformation 9.7
422 autonomic dysfunction 9.7
423 cytomegalovirus infection 9.7
424 dysphagia 9.7
425 paresthesia 9.7
426 pituitary tumors 9.7
427 seizure disorder 9.7
428 tremor 9.7
429 glial tumor 9.7
430 low-flow priapism 9.7
431 inflammatory myopathy with abundant macrophages 9.7
432 familial ovarian cancer 9.7
433 growing teratoma syndrome 9.7
434 osteonecrosis of the jaw 9.7
435 rare soft tissue tumor 9.7
436 pik3ca-related overgrowth syndrome 9.7
437 diffuse alveolar hemorrhage 9.7
438 premature aging 9.7
439 intestinal polyposis syndrome 9.7
440 streptococcal toxic-shock syndrome 9.7
441 pfeiffer syndrome 9.7
442 pilomatrixoma 9.7
443 intussusception 9.7
444 medulloblastoma 9.7
445 teratoma, ovarian 9.7
446 papillomatosis, confluent and reticulated 9.7
447 small cell cancer of the lung 9.7
448 thanatophoric dysplasia, type i 9.7
449 thanatophoric dysplasia, type ii 9.7
450 thyroid cancer, nonmedullary, 2 9.7
451 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.7
452 pituitary adenoma 4, acth-secreting 9.7
453 galactorrhea 9.7
454 hypogonadism, male 9.7
455 myasthenia gravis 9.7
456 thymoma, familial 9.7
457 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.7
458 langerhans cell histiocytosis 9.7
459 mycobacterium tuberculosis 1 9.7
460 carney complex variant 9.7
461 neuroblastoma 2 9.7
462 fetal hemoglobin quantitative trait locus 6 9.7
463 deficiency anemia 9.7
464 persistent mullerian duct syndrome 9.7
465 adrenal cortical adenoma 9.7
466 visual agnosia 9.7
467 primary pigmented nodular adrenocortical disease 9.7
468 lung abscess 9.7
469 hereditary lymphedema i 9.7
470 bladder exstrophy-epispadias-cloacal exstrophy complex 9.7
471 sparganosis 9.7
472 cholelithiasis 9.7
473 thalassemia 9.7
474 gastric ulcer 9.7
475 erysipelas 9.7
476 pulmonary edema 9.7
477 testicular leukemia 9.7
478 hepatitis a 9.7
479 amenorrhea 9.7
480 rete testis adenocarcinoma 9.7
481 neuroendocrine tumor 9.7
482 duodenal ulcer 9.7
483 neuroendocrine carcinoma 9.7
484 melanoma 9.7
485 leiomyosarcoma 9.7
486 gangliocytoma 9.7
487 acromegaly 9.7
488 thrombophilia 9.7
489 cystadenoma 9.7
490 myoma 9.7
491 sertoli-leydig cell tumor 9.7
492 plexiform schwannoma 9.7
493 thymoma 9.7
494 fibrosarcoma 9.7
495 histiocytosis 9.7
496 mammary paget's disease 9.7
497 superior mesenteric artery syndrome 9.7
498 aortic aneurysm 9.7
499 hermaphroditism 9.7
500 cranial nerve palsy 9.7
501 pituitary adenoma 9.7
502 ectomesenchymoma 9.7
503 liver disease 9.7
504 agnosia 9.7
505 hypokalemia 9.7
506 ganglioneuroma 9.7
507 cavernous hemangioma 9.7
508 nelson syndrome 9.7
509 plexiform neurofibroma 9.7
510 testicular granulosa cell tumor 9.7
511 mediastinal cancer 9.7
512 ovarian germ cell teratoma 9.7
513 malignant mesenchymoma 9.7
514 juvenile type testicular granulosa cell tumor 9.7
515 radiation cystitis 9.7
516 end stage renal disease 9.7
517 fetal adenoma 9.7
518 tertiary syphilis 9.7
519 appendicitis 9.7
520 neurofibromatosis 9.7
521 krukenberg carcinoma 9.7
522 neurofibroma 9.7
523 renal tuberculosis 9.7
524 3-beta-hydroxysteroid dehydrogenase deficiency 9.7
525 blastic plasmacytoid dendritic cell 9.7
526 carcinoid syndrome 9.7
527 complete androgen insensitivity syndrome 9.7
528 dendritic cell tumor 9.7
529 gigantism 9.7
530 lymphosarcoma 9.7
531 ovarian epithelial cancer 9.7
532 ring chromosome 3 9.7
533 true thymic hyperplasia 9.7
534 syncope 9.7
535 posttransplant acute limbic encephalitis 9.7
536 benign peripheral nerve sheath tumor 9.7
537 virus-associated trichodysplasia spinulosa 9.7
538 polyploidy 9.7

Graphical network of the top 20 diseases related to Testicular Cancer:



Diseases related to Testicular Cancer

Symptoms & Phenotypes for Testicular Cancer

Drugs & Therapeutics for Testicular Cancer

Drugs for Testicular Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 196, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Testosterone Approved, Experimental, Investigational Phase 4 58-22-0, 481-30-1 10204 6013
2
Methyltestosterone Approved Phase 4 58-18-4 6010
3
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
4
Testosterone enanthate Approved Phase 4 315-37-7 9416
5
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
6
Polyestradiol phosphate Approved Phase 4 28014-46-2
7
Docetaxel Approved, Investigational Phase 4 114977-28-5 148124
8
Tyrosine Approved, Investigational, Nutraceutical Phase 4 60-18-4 6057
9 Androgens Phase 4
10 Follicle Stimulating Hormone Phase 4
11 Testosterone 17 beta-cypionate Phase 4
12 Estradiol 17 beta-cypionate Phase 4
13 Estradiol 3-benzoate Phase 4
14
Lenograstim Approved, Investigational Phase 3 135968-09-1
15
Oxaliplatin Approved, Investigational Phase 3 61825-94-3 43805 6857599 5310940 9887054
16
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
17
Cisplatin Approved Phase 3 15663-27-1 2767 441203 84093
18
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
19
Ifosfamide Approved Phase 3 3778-73-2 3690
20
Etoposide Approved Phase 3 33419-42-0 36462
21
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
22
Temozolomide Approved, Investigational Phase 3 85622-93-1 5394
23
leucovorin Approved Phase 3 58-05-9 6006 143
24
Vinblastine Approved Phase 3 865-21-4 241903 13342
25
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
26
Methotrexate Approved Phase 3 59-05-2, 1959-05-2 126941
27
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
28
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
29
Irinotecan Approved, Investigational Phase 3 97682-44-5, 100286-90-6 60838
30
Castor oil Approved, Investigational, Nutraceutical, Vet_approved Phase 2, Phase 3 8001-79-4
31
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
32 Anabolic Agents Phase 2, Phase 3
33 Cathartics Phase 2, Phase 3
34 Castor Phase 2, Phase 3
35 Laxatives Phase 2, Phase 3
36 Calcium, Dietary Phase 3
37 Immunologic Factors Phase 3
38 Tubulin Modulators Phase 3
39 Anti-Infective Agents Phase 3
40 Immunosuppressive Agents Phase 3
41 Antimetabolites Phase 3
42 Antimitotic Agents Phase 3
43 Etoposide phosphate Phase 3
44 Alkylating Agents Phase 3
45
Isophosphamide mustard Phase 3 0
46 Anti-Bacterial Agents Phase 3
47 Antibiotics, Antitubercular Phase 3
48 Antirheumatic Agents Phase 3
49 Dermatologic Agents Phase 3
50 Micronutrients Phase 3
51 Trace Elements Phase 3
52 Vitamins Phase 3
53 Antidotes Phase 3
54 Vitamin B Complex Phase 3
55 Nutrients Phase 3
56 Folate Phase 3
57 Protective Agents Phase 3
58 Vitamin B9 Phase 3
59 topoisomerase I inhibitors Phase 3
60 Folic Acid Antagonists Phase 3
61
Liposomal doxorubicin Phase 3 31703
62
Calcium Nutraceutical Phase 3 7440-70-2 271
63
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
64
Furosemide Approved, Vet_approved Phase 1, Phase 2 54-31-9 3440
65
Mannitol Approved, Investigational Phase 1, Phase 2 69-65-8 6251 453
66
Chlorpheniramine Approved Phase 1, Phase 2 132-22-9, 113-92-8 2725
67
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 1, Phase 2 7487-88-9 24083
68
Lorazepam Approved Phase 2 846-49-1 3958
69
Everolimus Approved Phase 2 159351-69-6 70789204 6442177
70
Ondansetron Approved Phase 2 99614-02-5 4595
71
Palbociclib Approved, Investigational Phase 2 571190-30-2 5005498 11431660 5330286
72
Carmustine Approved, Investigational Phase 2 154-93-8 2578
73
Levoleucovorin Approved, Investigational Phase 2 68538-85-2
74
Fluorouracil Approved Phase 2 51-21-8 3385
75
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
76
Celecoxib Approved, Investigational Phase 1, Phase 2 169590-42-5 2662
77
Fosaprepitant Approved Phase 2 172673-20-0 219090
78
Palonosetron Approved, Investigational Phase 2 135729-56-5, 119904-90-4 148211
79
Aprepitant Approved, Investigational Phase 2 170729-80-3 6918365 151165
80
Epirubicin Approved Phase 2 56420-45-2 41867
81
Durvalumab Approved, Investigational Phase 1, Phase 2 1428935-60-7
82
Thiotepa Approved, Investigational Phase 2 52-24-4 5453
83
Ciprofloxacin Approved, Investigational Phase 1, Phase 2 85721-33-1 2764
84
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2 1177-87-3
85
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
86
Peppermint Approved Phase 2
87 Orange Approved Phase 2
88
Ethanol Approved Phase 2 64-17-5 702
89
alemtuzumab Approved, Investigational Phase 2 216503-57-0
90
Mesna Approved, Investigational Phase 2 3375-50-6 598
91
Melphalan Approved Phase 2 148-82-3 460612 4053
92
Bevacizumab Approved, Investigational Phase 2 216974-75-3
93
Mechlorethamine Approved, Investigational Phase 2 51-75-2 4033
94
Pembrolizumab Approved Phase 2 1374853-91-4
95
Iron Approved, Experimental Phase 2 15438-31-0, 7439-89-6 27284 23925
96
Deferasirox Approved, Investigational Phase 2 201530-41-8 5493381
97
Alvocidib Experimental, Investigational Phase 2 131740-09-5, 146426-40-6 5287969
98
Tremelimumab Investigational Phase 1, Phase 2 745013-59-6
99 Tempol Investigational Phase 2 2226-96-2
100 Ranitidine bismuth citrate Phase 1, Phase 2
101 Anesthetics Phase 2
102 Technetium Tc 99m-ethylenedicysteine Phase 2
103 Radiopharmaceuticals Phase 2
104 Fluorodeoxyglucose F18 Phase 2
105 Cola Phase 2
106 Neurotransmitter Agents Phase 2
107 Anti-Anxiety Agents Phase 2
108 Psychotropic Drugs Phase 2
109 Antipsychotic Agents Phase 2
110 Cyclin-Dependent Kinase Inhibitor Proteins Phase 2
111 Hematinics Phase 2
112 Angiogenesis Inhibitors Phase 2
113
Erlotinib Hydrochloride Phase 1, Phase 2 183319-69-9 176871
114 neurokinin A Phase 2
115 Emetics Phase 2
116
Substance P Phase 2 33507-63-0 44359816
117 Hormone Antagonists</